XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.20.2

Common Stock and Stock-Based Awards Plans | 9 Months Ended
--- | ---
Sep. 30, 2020
Common Stock and Stock-Based Awards Plans |
Common Stock and Stock-Based Awards Plans | Note 8 – Common Stock and Stock-Based Awards Plans Dividends The Company began declaring and paying quarterly dividends during the first quarter of 2018. For the nine months ended September 30, 2020, cash dividends paid totaled $17.2 million. On September 11, 2020, the Company declared a quarterly cash dividend of $0.16 per share of the Company’s common stock to shareholders of record as of September 30, 2020. The dividend in the aggregate amount of $5.8 million was paid on October 14, 2020. The Company’s future dividend policy is subject to the Company’s compliance with applicable law, and depending on, among other things, the Company’s results of operations, financial condition, level of indebtedness, capital requirements, contractual restrictions, restrictions in the Company’s debt agreements, and other factors that the Board of Directors may deem relevant, including the impact of the COVID-19 pandemic. Dividend payments are not mandatory or guaranteed; there can be no assurance that the Company will continue to pay a dividend in the future. Share Repurchase Authorization On February 19, 2020, the Board of Directors authorized a $150 million increase to its existing stock repurchase program. On October 26, 2018, the Board of Directors authorized the repurchase of $100 million of the Company’s common stock in addition to the $250 million previously approved on March 6, 2018. During the nine months ended September 30, 2020, the Company repurchased a total of 0.7 million common shares for an aggregate of $19.3 million at an average price of $26.69 per share. As of September 30, 2020, the Company had an aggregate $210.1 million remaining under its stock repurchase program. Stock-Based Compensation The Company’s 2019 Omnibus Incentive Compensation Plan (the 2019 Plan) authorizes the Company, upon approval of the Compensation Committee of the Board of Directors, to grant a variety of awards, including stock options, restricted shares and restricted stock units (both time-based and performance-based) and other forms of equity awards, or any combination thereof, to any director, officer, employee or consultant (including any prospective director, officer, employee or consultant) of the Company. Stock options (which have not been awarded since 2015) are granted to employees with an exercise price equal to the market price of the Company’s common stock on the date of grant, generally vest over a four-year period from the date of grant and have a term of 10 years. Time-based restricted stock units granted to employees generally vest over a four-year period from the date of grant, subject to the continued employment of the employee by the Company. Performance-based restricted stock units generally vest over a three-year performance cycle, which includes the year of the grant, and are based upon the Company’s achievement of specified performance metrics. Awards under the 2019 Plan to non-employee directors have been in the form of restricted stock units, which vest in equal annual installments over a one-year period, starting on the grant date. As of September 30, 2020, 2.7 million common shares were available for issuance under the Company’s 2019 Plan. All share-based payments to employees, including grants of employee stock options, are recognized in the financial statements based on their grant date fair values. The total compensation cost recognized for stock-based awards was $3.4 million and $9.5 million for the three and nine months ended September 30, 2020, respectively, and $2.7 million and $8.5 million for the three and nine months ended September 30, 2019, respectively. The total income tax benefit recognized in the Condensed Consolidated Statements of Income for stock-based awards was $0.8 million and $2.3 million for the three and nine months ended September 30, 2020, respectively, and $0.7 million and $2.0 million for the three and nine months ended September 30, 2019, respectively. Awards of restricted stock units and performance-based restricted stock units are valued at the closing market price of the Company’s common stock on the date of grant. For performance-based restricted stock units, compensation expense is based on the probability that the performance goals will be achieved, which is monitored by management throughout the requisite service period. When it becomes probable, based on the Company’s expectation of performance during the measurement period, that more or less than the previous estimate of the awarded shares will vest, an adjustment to stock-based compensation expense is recognized as a change in accounting estimate. As of September 30, 2020, the unrecognized compensation cost and remaining weighted-average amortization period related to stock-based awards were as follows:
|  |  |  |  |  | Performance-
|  |  |  | Time-based |  | based
|  |  |  | Restricted |  | Restricted
|  |  |  | Stock |  | Stock
(in thousands, except remaining period data) |  |  |  | Units |  | Units(1)
Unrecognized compensation cost |  |  |  | $ 22,573 |  | $ 5,570
Remaining weighted-average |  |  |  |  |  |  |  |
amortization period |  |  |  | 2.7 years |  | 1.7 years
(1) Based on the probable achievement of the performance goals identified in each award.
The total cash received by the Company as a result of stock option exercises for the nine months ended September 30, 2020 and 2019 was approximately $0.4 million and $1.3 million, respectively. The actual tax benefit realized as a result of stock option exercises and the vesting of other share-based awards during the nine months ended September 30, 2020 and 2019 was $1.8 million and $1.7 million, respectively. For the nine months ended September 30, 2020 and 2019, the total intrinsic value of stock options exercised was $0.1 million and $0.4 million, respectively.The Company awarded performance-based restricted stock units to employees during the nine months ended September 30, 2020 and 2019. The number of performance-based restricted stock units that will ultimately be earned will not be determined until the end of the corresponding performance periods, and may vary from as low as zero to as high as 2.5 times the target number depending on the level of achievement of certain performance goals. The level of achievement of these goals is based upon the financial results of the Company for the last full calendar year within the performance period. The performance goals consist of certain levels of achievement using the following financial metrics: revenue, operating income margin, and return on invested capital. If the performance goals are not met based on the Company’s financial results, the applicable performance-based restricted stock units will not vest and will be forfeited. Shares subject to forfeited performance-based restricted stock units will be available for issuance under the Company’s 2019 Plan.The following table summarizes activities relating to the Company’s stock options:
|  |  |  |  |  | Weighted- |  |
|  |  |  | Weighted- |  | Average |  | Aggregate
|  | Number of |  | Average |  | Remaining |  | Intrinsic
|  | Options |  | Exercise |  | Contractual |  | Value
|  | (in thousands) |  | Price |  | Term (Years) |  | (in thousands)
Outstanding as of December 31, 2019 |  | 270 |  | $20.02 |  |  |  |
Exercised |  | (20) |  | 22.60 |  |  |  |
Outstanding and exercisable as of September 30, 2020 |  | 250 |  | $19.81 |  | 2.66 |  | $ 425
The aggregate intrinsic value in the table above is before income taxes and is calculated as the difference between the exercise price of the underlying options and the Company’s closing stock price as of the last business day of the period ended September 30, 2020 for options that had exercise prices that were below the closing price.The following table summarizes the activities related to the Company’s time-based restricted stock units:
|  |  |  |  | Weighted-
|  | Number of |  |  | Average
|  | Units |  |  | Grant Date
|  | (in thousands) |  |  | Fair Value
Non-vested awards outstanding as of December 31, 2019 |  | 893 |  |  | $28.06
Granted |  | 525 |  |  | 26.61
Vested |  | (301) |  |  | 27.61
Forfeited |  | (45) |  |  | 28.60
Non-vested awards outstanding as of September 30, 2020 |  | 1,072 |  |  | $27.45
The following table summarizes the activities related to the Company’s performance-based restricted stock units:
|  |  |  |  |  | Weighted-
|  |  | Number of |  |  | Average
|  |  | Units |  |  | Grant Date
|  |  | (in thousands) |  |  | Fair Value
Non-vested awards outstanding as of December 31, 2019 |  |  | 384 |  |  | $28.89
Granted (1) |  |  | 165 |  |  | 28.02
Forfeited |  |  | (181) |  |  | 30.04
Non-vested awards outstanding as of September 30, 2020 |  |  | 368 |  |  | $27.93
(1) Represents target number of units that can vest based on the achievement of the performance goals.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration